But Biogen isn’t resting on the success of Spinraza. In January 2022, the big biotech exercised an option from Ionis for an exclusive global license for another antisense oligonucleotide, BIIB115, ...
Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback